EMEA-001687-PIP01-14-M06
Table of contents
Key facts
| Invented name |
Rukobia
|
| Active substance |
fostemsavir (tromethamine)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0067/2022
|
| PIP number |
EMEA-001687-PIP01-14-M06
|
| Pharmaceutical form(s) |
Prolonged-release tablet
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
ViiV Healthcare UK Ltd
+44 (0)7467 443192 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|